Healthcare provider profile · identity verified

Omar A Gomez, MD

Internal Medicine · PHARR, TX · NPI 1871667493

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	623	318
Levothyroxine Sodium	Levothyroxine Sodium	410	207
Gabapentin	Gabapentin	261	148
Amlodipine Besylate	Amlodipine Besylate	253	129
Lisinopril	Lisinopril	251	129
Telmisartan	Telmisartan	246	129
Metoprolol Succinate	Metoprolol Succinate	240	125
Metformin Hcl	Metformin Hcl	208	108
Sertraline Hcl	Sertraline Hcl	206	119
Tamsulosin Hcl	Tamsulosin Hcl	200	103
Omeprazole	Omeprazole	181	103
Ezetimibe	Ezetimibe	173	108
Montelukast Sodium	Montelukast Sodium	141	83
Ozempic	Semaglutide	141	53
Rosuvastatin Calcium	Rosuvastatin Calcium	125	67
Buspirone Hcl	Buspirone Hcl	122	71
Cefdinir	Cefdinir	122	109
Jardiance	Empagliflozin	117	69
Furosemide	Furosemide	116	64
Famotidine	Famotidine	114	66
Losartan Potassium	Losartan Potassium	114	62
Duloxetine Hcl	Duloxetine Hcl	105	55
Alendronate Sodium	Alendronate Sodium	103	46
Pantoprazole Sodium	Pantoprazole Sodium	101	58
Fenofibrate	Fenofibrate Nanocrystallized	92	51
Pioglitazone Hcl	Pioglitazone Hcl	91	52
Nifedipine Er	Nifedipine	87	47
Myrbetriq	Mirabegron	86	36
Vascepa	Icosapent Ethyl	85	53
Clopidogrel	Clopidogrel Bisulfate	84	41
Mounjaro	Tirzepatide	83	35
Quetiapine Fumarate	Quetiapine Fumarate	82	41
Metoprolol Tartrate	Metoprolol Tartrate	77	35
Olmesartan Medoxomil	Olmesartan Medoxomil	77	42
Donepezil Hcl	Donepezil Hcl	69	37
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	69	40
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	64	52
Farxiga	Dapagliflozin Propanediol	61	30
Carvedilol	Carvedilol	60	36
Memantine Hcl	Memantine Hcl	60	29
Finasteride	Finasteride	59	34
Hydrochlorothiazide	Hydrochlorothiazide	58	30
Icosapent Ethyl	Icosapent Ethyl	58	39
Meclizine Hcl	Meclizine Hcl	58	30
Mirtazapine	Mirtazapine	58	33
Ipratropium Bromide	Ipratropium Bromide	57	36
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	57	48
Baclofen	Baclofen	56	36
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	47
Gemtesa	Vibegron	51	22
Linzess	Linaclotide	50	27
Celecoxib	Celecoxib	49	39
Fluticasone Propionate	Fluticasone Propionate	48	30
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	48	20
Trazodone Hcl	Trazodone Hcl	48	28
Atenolol	Atenolol	47	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	25
Januvia	Sitagliptin Phosphate	41	22
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	41	27
Glimepiride	Glimepiride	39	24
Paxlovid	Nirmatrelvir/Ritonavir	39	39
Veltassa	Patiromer Calcium Sorbitex	39	18
Eliquis	Apixaban	38	21
Prednisone	Prednisone	36	30
Sps	Sodium Polystyrene Sulfon/Sorb	35	32
Doxazosin Mesylate	Doxazosin Mesylate	34	20
Xarelto	Rivaroxaban	34	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	15
Albuterol Sulfate Hfa	Albuterol Sulfate	32	17
Allopurinol	Allopurinol	31	19
Rybelsus	Semaglutide	31	16
Terbinafine Hcl	Terbinafine Hcl	31	20
Spironolactone	Spironolactone	30	18
Glipizide	Glipizide	29	13
Glipizide Er	Glipizide	29	13
Trulicity	Dulaglutide	29	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	15
Pravastatin Sodium	Pravastatin Sodium	27	19
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	27	14
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	27	suppressed
Levofloxacin	Levofloxacin	26	24
Metformin Hcl Er	Metformin Hcl	26	17
Ramipril	Ramipril	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	15
Meloxicam	Meloxicam	25	18
Ciclopirox	Ciclopirox	24	15
Doxycycline Hyclate	Doxycycline Hyclate	24	18
Tresiba Flextouch U-100	Insulin Degludec	24	13
Cholestyramine	Cholestyramine (With Sugar)	23	15
Kerendia	Finerenone	23	14
Levemir Flexpen	Insulin Detemir	23	suppressed
Tresiba Flextouch U-200	Insulin Degludec	23	14
Dutasteride	Dutasteride	22	11
Paroxetine Hcl	Paroxetine Hcl	22	12
Sulfasalazine	Sulfasalazine	22	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	22	12
Potassium Chloride	Potassium Chloride	21	12
Pregabalin	Pregabalin	21	suppressed
Ranolazine Er	Ranolazine	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	11
Digoxin	Digoxin	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	15
Lagevrio (Eua)	Molnupiravir	19	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Synjardy	Empagliflozin/Metformin Hcl	19	suppressed
Tradjenta	Linagliptin	19	12
Ursodiol	Ursodiol	19	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	18	12
Azithromycin	Azithromycin	17	17
Cefuroxime	Cefuroxime Axetil	17	17
Esomeprazole Magnesium	Esomeprazole Magnesium	17	11
Levetiracetam	Levetiracetam	17	suppressed
Mupirocin	Mupirocin	16	suppressed
Prolia	Denosumab	16	16
Risperidone	Risperidone	16	suppressed
Simvastatin	Simvastatin	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Vilazodone Hcl	Vilazodone Hcl	16	suppressed
Vraylar	Cariprazine Hcl	16	11
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	15
Entresto	Sacubitril/Valsartan	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Primidone	Primidone	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Fluconazole	Fluconazole	14	13
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	14	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	14	suppressed
Valsartan	Valsartan	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Metronidazole	Metronidazole	12	12
Ondansetron Hcl	Ondansetron Hcl	12	11
Sucralfate	Sucralfate	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Trulance	Plecanatide	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error